Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 236

The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.

Mortality in Pulmonary Arterial Hypertension in the Modern Era: Early Insights From the Pulmonary Hypertension Association Registry

Open access
Chang, Kevin Y., Duval, Sue, Badesch, David B., Bull, Todd M., Chakinala, Murali M., De Marco, Teresa, Frantz, Robert P., Hemnes, Anna, Mathai, Stephen C., Rosenzweig, Erika Berman, Ryan, John J., Thenappan, Thenappan, Allen, Roblee, Bartolome, Sonja, Benza, Raymond, Cadaret, Linda, Eggert, Michael, Elwing, Jean, Fineman, Jeffrey, Foley, Raymond, Ford, H. James, Hirsch, Russel, Grinnan, James, Ivy, D. Dunbar, Kawut, Steven, Kennedy, Jamie, Klinger, James, Leary, Peter, Mazimba, Sula, Ramani, Gautam, Raina, Amresh, Runo, James, Swisher, John, Varghese, Nidhy, White, R. James, Williamson, Timothy, Yung, Delphine, Zamanian, Roham, Zwicke, Dianne · 2022 · Journal of the American Heart Association

Abstract

Background: Current mortality data for pulmonary arterial hypertension (PAH) in the United States are based on registries that enrolled patients prior to 2010. We sought to determine mortality in PAH in the modern era using the PHAR (Pulmonary Hypertension Association Registry). Methods and Results: We identified all adult patients with PAH enrolled in the PHAR between September 2015 and September 2020 (N=935). We used Kaplan‐Meier survival analysis and Cox proportional hazards models to assess mortality at 1, 2, and 3 years. Patients were stratified based on disease severity by 3 validated risk scores. In treatment‐naïve patients, we compared survival based on initial treatment strategy. The median age was 56 years (44–68 years), and 76% were women. Of the 935 patients, 483 (52%) were ≤6 months from PAH diagnosis. There were 121 deaths (12.9%) during a median follow‐up time of 489 days (281–812 days). The 1‐, 2‐, and 3‐year mortality was 8% (95% CI, 6%–10%), 16% (95% CI, 13%–19%), and 21% (95% CI, 17%–25%), respectively. When stratified into low‐, intermediate‐, and high‐risk PAH, the mortality at 1, 2, and 3 years was 1%, 4% to 6%, and 7% to 11% for low risk; 7% to 8%, 11% to 16%, and 18% to 20% for intermediate risk; and 12% to 19%, 22% to 38%, and 28% to 55% for high risk, respectively. In treatment‐naïve patients, initial combination therapy was associated with better 1‐year survival (adjusted hazard ratio, 0.43 [95% CI, 0.19–0.95]; P =0.037). Conclusions: Mortality in the intermediate‐ and high‐risk patients with PAH remains unacceptably high in the PHAR, suggesting the importance for early diagnosis, aggressive use of available therapies, and the need for better therapeutics.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1161/jaha.121.024969

Cites

4 of 4 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 4 references

Cited by

See all 236

Metadata

Authors
Chang, K. Y., Duval, S., Badesch, D. B., Bull, T. M., Chakinala, M. M., De Marco, T., Frantz, R. P., Hemnes, A., Mathai, S. C., Rosenzweig, E. B., Ryan, J. J., Thenappan, T., Allen, R., Bartolome, S., Benza, R., Cadaret, L., Eggert, M., Elwing, J., Fineman, J., Foley, R., Ford, H. J., Hirsch, R., Grinnan, J., Ivy, D. D., Kawut, S., Kennedy, J., Klinger, J., Leary, P., Mazimba, S., Ramani, G., Raina, A., Runo, J., Swisher, J., Varghese, N., White, R. J., Williamson, T., Yung, D., Zamanian, R., & Zwicke, D.
Venue
Journal of the American Heart Association
Published
2022-05-03
Volume
11
Issue
9
Pages
e024969-e024969
ISSN
2047-9980 (ISSN-L)
OpenAlex
W4224981623
Cited by
236
References
4
FWCI
25.79
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Mortality in Pulmonary Arterial Hypertension in the Modern Era: Early Insights From the Pulmonary Hypertension Association Registry. https://app.cochat.ai/papers/10.1161/jaha.121.024969
The paper
Chang, K. Y., Duval, S., Badesch, D. B., Bull, T. M., Chakinala, M. M., De Marco, T., Frantz, R. P., Hemnes, A., Mathai, S. C., Rosenzweig, E. B., Ryan, J. J., Thenappan, T., Allen, R., Bartolome, S., Benza, R., Cadaret, L., Eggert, M., Elwing, J., Fineman, J., . . . Zwicke, D. (2022). Mortality in Pulmonary Arterial Hypertension in the Modern Era: Early Insights From the Pulmonary Hypertension Association Registry. Journal of the American Heart Association. https://doi.org/10.1161/jaha.121.024969

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.